Advertisement
News
Subscribe to MDT Magazine News

SABCS 2010: Interview with Rowan T. Chlebowski, M.D. Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Chlebowski, lead investigator for the Women's Health Initiative, discusses the initiative's findings about the use of hormone therapy and its influence on cancer incidence and related cancer mortality, and the effects of bisphosphonates on breast cancer risk.

TOPICS:

SABCS 2010: Interview with Laura Esserman, M.D., M.B.A.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Esserman discusses her philosophy of holistic treatment and involving patients in the decision-making process, a cancer risk tracking system, and the I-Spy trials that match treatments to patients based on biomarkers.

TOPICS:

SABCS 2010: Interview with Klaus Pantel, M.D., Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.

TOPICS:
Advertisement

SABCS 2010: Interview with Edith A. Perez, M.D.

December 11, 2010 6:35 am | by AACR | Comments

In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.

TOPICS:

SABCS 2010: Interview with Charles M. Perou, Ph.D.

December 11, 2010 6:35 am | by AACR | Comments

Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.

TOPICS:

SABCS 2010: Interview with Rochelle Shoretz

December 11, 2010 6:35 am | by AACR | Comments

Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.

TOPICS:

SABCS 2010: Interview with Sandi Stanford

December 11, 2010 6:34 am | by AACR | Comments

Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.

TOPICS:

SABCS 2010: HER2 Teleconference

December 11, 2010 5:34 am | by AACR | Comments

Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.

TOPICS:
Advertisement

SABCS 2010: Circulating Tumor Cells and Metastasis Teleconference

December 11, 2010 5:34 am | by AACR | Comments

Minetta Liu, M.D., director of translational breast cancer research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, hosts this press conference.

TOPICS:

Govt won't contest ruling in steroids probe

December 10, 2010 5:45 pm | by PETE YOST - Associated Press - Associated Press | Comments

The government will not contest an appeals court ruling that investigators illegally seized a list of baseball players who allegedly tested positive for steroids, the Justice Department said Friday. That decision keeps intact a legal victory for scores of ballplayers snared in the doping...

Dental Products Panel to Consider Amalgam, Mercury Safety Issues

December 10, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

The FDA’s Dental Products Panel will be asked this week to consider what scientific methodology is needed to determine unsafe levels of dental amalgam and mercury, especially for children and other vulnerable patients.

TOPICS:

CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys(2)

December 10, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the...

TOPICS:

CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys

December 10, 2010 2:31 pm | Comments

As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the...

Summary Box: Analysts criticize Tenet deal price

December 10, 2010 1:45 pm | by The Associated Press | Comments

THE OPINION: Analysts say Community Health Systems Inc.'s $3 billion offer for Tenet Healthcare Corp. is too low but might inspire other suitors to start a bidding war.DEAL DETAILS: Community Health has offered $5 in cash and $1 in stock per Tenet share, marking a 40 percent premium to Tenet's last...

Thornridge takes stake in Assisted Living

December 10, 2010 12:45 pm | by The Associated Press | Comments

Senior living facility operator Assisted Living Concepts Inc. said Friday its largest shareholder, Scotia Investments Ltd., has transferred its shares to a former affiliate, Thornridge Holdings Ltd.The transfer is part of the reorganization by Scotia Investments.Assisted Living said it doesn't...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading